Catalyst Wire Dossier Catalyst Wire Dossier

QUILT-3.090 NANT SCC Vaccine

NANT Squamous Cell Carcinoma Vaccine · ImmunityBio, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QUILT-3.090 NANT SCC Vaccine, covering 2024-08-05 to 2024-08-05. Get the full timeline:

Most recent: Clinical Trial Update: QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have Progressed [Phase 1, Phase 2]

See pricing